Showing results (211-220 of 263) with videos related to
Sort By:
Pageof 27
Cancer|March 30, 2000
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedulesD F Bajorin, J A McCaffrey, P M Dodd, et al.Cancer|June 1, 1990
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative groupP E Postmus, T A Splinter, F M Palmen, et al.Cancer Research|June 15, 1991
Clinical pharmacology of deoxyspergualin in patients with advanced cancerJ F Muindi, S J Lee, L Baltzer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Inverse associations between plasma lycopene and other carotenoids and prostate cancerQ Y Lu, J C Hung, D Heber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.Cancer Research|October 15, 1992
Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expressionR J Motzer, D M Nanus, P O'Moore, et al.Urologic Oncology|January 14, 2011
Reversal of the low-affinity neurotrophin receptor stromal-epithelial expression pattern between benign and malignant human prostateC N Papandreou, T Bogenrieder, C L Finstad, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1993
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancerA D Seidman, H I Scher, J L Gabrilove, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 1991
Twice daily thoracic irradiation for limited small cell lung cancerJ G Armstrong, M M Rosenstein, M G Kris, et al.Pageof 27